Hypophosphatemia: Unlocking the Key To Improved Diagnosis and Management

Symposium Details: 2:30–3:30 PM EDT on September 11, 2020; certified for 1.0 AMA PRA Category 1 Credit™ and ABIM MOC point.

Co-Chairs: Michael A. Levine, MD
Leanne M. Ward, MD

This clinical program will focus on clinical presentations on the state of care, challenges, and emerging therapies of Hypophosphatemia.

• X-linked Hypophosphatemia Update: History and Future Goals of Treatment
• Tumor-Induced Osteomalacia Diagnosis and Imaging
• Tumor-Induced Osteomalacia Management and Therapeutic Goals
• Patient Perspective
• Audience Q&A with Patient and Expert Faculty

Registration is complimentary and open to anyone with Endocrine Society login credentials. You can select to add this symposium to an existing EBR and/or CEU registration or register for it as a standalone event. Simply click the button below and proceed through the prompts.

We thank Ultragenyx Pharmaceuticals for supporting this program.